We are live on
!
Find out more
AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
46 hedge funds and large institutions have $8.33M invested in Accelerate Diagnostics in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
3,300% more call options, than puts
Call options by funds: $34K | Put options by funds: $1K
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
67% more capital invested
Capital invested by funds: $4.98M → $8.33M (+$3.35M)
12% more funds holding
Funds holding: 41 → 46 (+5)
64% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 11
Holders
46
Holders Change
+5
Holders Change %
+12.2%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
11
Closed
3
Calls
$34K
Puts
$1K
Net Calls
+$33K
Net Calls Change
+$10K
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$730K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$234K |
| 3 |
Renaissance Technologies
New York
|
+$60.9K |
| 4 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$29.4K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$18.5K |
Top Sellers
| 1 |
GAM
Griffin Asset Management
New York
|
-$200K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$15.7K |
| 3 |
VF
Virtu Financial
New York
|
-$12K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$11.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.95K |
